152 related articles for article (PubMed ID: 27328814)
1. Kinetics of calcium oxalate crystal formation in urine.
Laube N; Klein F; Bernsmann F
Urolithiasis; 2017 Apr; 45(2):151-157. PubMed ID: 27328814
[TBL] [Abstract][Full Text] [Related]
2. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
[TBL] [Abstract][Full Text] [Related]
3. Testing the predictability of the relative urinary supersaturation from the Bonn-Risk-Index for calcium oxalate stone formation.
Laube N; Hergarten S; Hesse A
Clin Chem Lab Med; 2001 Oct; 39(10):966-9. PubMed ID: 11758612
[TBL] [Abstract][Full Text] [Related]
4. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
Porowski T; Zoch-Zwierz W; Konstantynowicz J; Taranta-Janusz K
Pediatr Nephrol; 2008 Jul; 23(7):1123-8. PubMed ID: 18335253
[TBL] [Abstract][Full Text] [Related]
5. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
[TBL] [Abstract][Full Text] [Related]
6. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
Kavanagh JP; Laube N
J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
[TBL] [Abstract][Full Text] [Related]
7. [New diagnostic tool for individual monitoring of urolithiasis risk and other metabolic diseases].
Laube N; Klein F; Bernsmann F; Fisang C
Dtsch Med Wochenschr; 2014 Aug; 139(34-35):1721-5. PubMed ID: 25116022
[TBL] [Abstract][Full Text] [Related]
8. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
Laube N; Schmidt M; Hesse A
Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
[TBL] [Abstract][Full Text] [Related]
10. Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.
Kavanagh JP; Nishio S; Garside J; Blacklock NJ
J Urol; 1993 Mar; 149(3):614-7. PubMed ID: 8437278
[TBL] [Abstract][Full Text] [Related]
11. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
[TBL] [Abstract][Full Text] [Related]
12. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
Laube N; Schneider A; Hesse A
Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
[TBL] [Abstract][Full Text] [Related]
13. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
14. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
15. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
Kavanagh JP; Jones L; Rao PN
Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
[TBL] [Abstract][Full Text] [Related]
16. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
Laube N; Zimmermann DJ
Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
[TBL] [Abstract][Full Text] [Related]
17. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?
Rodgers AL; Webber D; Hibberd B
Urolithiasis; 2015 Nov; 43(6):479-87. PubMed ID: 26198547
[TBL] [Abstract][Full Text] [Related]
18. The alteration of urine composition due to stone material present in the urinary tract.
Laube N; Pullmann M; Hergarten S; Schmidt M; Hesse A
Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
[TBL] [Abstract][Full Text] [Related]
19. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
20. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
Laube N; Rodgers A; Allie-Hamdulay S; Straub M
Clin Chem Lab Med; 2008; 46(8):1134-9. PubMed ID: 18578688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
